0

Encephalopathy Collection
 1-20 of 88 Articles
Articles |  7 September 2010
Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis: A Cohort Study
Manuel Romero-Gómez, MD, PhD; María Jover, PhD; José A. Del Campo, PhD; et al.
Ann Intern Med. 2010;153(5):281-288. doi:10.7326/0003-4819-153-5-201009070-00002
Editorials |  7 September 2010
Hepatic Encephalopathy in Our Genes?
Jan Albrecht, PhD
Ann Intern Med. 2010;153(5):335-336. doi:10.7326/0003-4819-153-5-201009070-00008
Reviews |  20 March 2007
Narrative Review: Fabry Disease
Joe T.R. Clarke, MD, PhD
Ann Intern Med. 2007;146(6):425-433. doi:10.7326/0003-4819-146-6-200703200-00007
Articles |  16 January 2007 FREE
Agalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial
Maryam Banikazemi, MD; Jan Bultas, MD, PhD; Stephen Waldek, MB, BCh; et al.
Ann Intern Med. 2007;146(2):77-86. doi:10.7326/0003-4819-146-2-200701160-00148
Editorials |  16 January 2007 FREE
Enzyme Replacement in Fabry Disease: The Essence Is in the Kidney
Raphael Schiffmann, MD
Ann Intern Med. 2007;146(2):142-144. doi:10.7326/0003-4819-146-2-200701160-00147
Current Clinical Issues |  15 November 2005
Why Prion Diseases Are a Mystery, and Why They Matter
Jennifer Fisher Wilson
Ann Intern Med. 2005;143(10):773-776. doi:10.7326/0003-4819-143-10-200511150-00037
Brief Communications |  1 March 1998
Severe Hyperbilirubinemia after Creation of Transjugular Intrahepatic Portosystemic Shunts: Natural History and Predictors of Outcome
Smita S. Rouillard, MD; Nathan M. Bass, MD, PhD; John P. Roberts, MD; et al.
Ann Intern Med. 1998;128(5):374-377. doi:10.7326/0003-4819-128-5-199803010-00006
Articles |  1 July 1997
Detection of the His1069Gln Mutation in Wilson Disease by Rapid Polymerase Chain Reaction
Theresia Maier-Dobersberger, MD; Peter Ferenci, MD; Claudia Polli; et al.
Ann Intern Med. 1997;127(1):21-26. doi:10.7326/0003-4819-127-1-199707010-00004
Editorials |  1 July 1997
Genetic Heterogeneity in Wilson Disease: Lessons from Rare Alleles
Reed Edwin Pyeritz, MD, PhD
Ann Intern Med. 1997;127(1):70-72. doi:10.7326/0003-4819-127-1-199707010-00011
Articles |  1 June 1997
Transjugular Intrahepatic Portosystemic Shunts Compared with Endoscopic Sclerotherapy for the Prevention of Recurrent Variceal Hemorrhage: A Randomized, Controlled Trial
Arun J. Sanyal, MD; Arthur M. Freedman, MD; Velimir A. Luketic, MD; et al.
Ann Intern Med. 1997;126(11):849-857. doi:10.7326/0003-4819-126-11-199706010-00001
Editorials |  1 June 1997
Transjugular Intrahepatic Portosystemic Shunts Versus Sclerotherapy: A Discussion of Discordant Results
Harold O. Conn, MD
Ann Intern Med. 1997;126(11):907-910. doi:10.7326/0003-4819-126-11-199706010-00010
Brief Communications |  1 December 1996
Pulmonary Hypertension Developing after Alglucerase Therapy in Two Patients with Type 1 Gaucher Disease Complicated by the Hepatopulmonary Syndrome
Arthur Dawson, MD; Darlene J. Elias, MD; David Rubenson, MD; et al.
Ann Intern Med. 1996;125(11):901-904. doi:10.7326/0003-4819-125-11-199612010-00005
Articles |  1 January 1995
Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources
Gregory A. Grabowski, MD; Norman W. Barton, MD, PhD; Gregory Pastores, MD; et al.
Ann Intern Med. 1995;122(1):33-39. doi:10.7326/0003-4819-122-1-199501010-00005
Brief Communications |  1 August 1994
Glucocerebrosidase Treatment of Type I Gaucher Disease with Severe Pulmonary Involvement
Michael Pelini, MD; Douglas Boice*, MD; Kevin O'Neil, MD; et al.
Ann Intern Med. 1994;121(3):196-197. doi:10.7326/0003-4819-121-3-199408010-00006
Articles |  1 December 1992
Postoperative Hyponatremic Encephalopathy in Menstruant Women
J. Carlos Ayus, MD; James M. Wheeler, MD, MPH; Allen I. Arieff, MD
Ann Intern Med. 1992;117(11):891-897. doi:10.7326/0003-4819-117-11-891
Brief Reports |  1 August 1992
Fabry Disease: An Unusual Cause of Severe Coronary Disease in a Young Man
Edward A. Fisher, MD; Robert J. Desnick, PhD, MD; Ronald E. Gordon, PhD; et al.
Ann Intern Med. 1992;117(3):221-223. doi:10.7326/0003-4819-117-3-221
Reviews |  1 November 1991
Wilson Disease: Clinical Presentation, Treatment, and Survival
Wolfgang Stremmel, MD; Karl-Wilhelm Meyerrose, MD; Claus Niederau, MD; et al.
Ann Intern Med. 1991;115(9):720-726. doi:10.7326/0003-4819-115-9-720
Articles |  15 July 1990
The Clinical Spectrum of the Eosinophilia-Myalgia Syndrome Associated with L-Tryptophan Ingestion: Clinical Features in 20 Patients and Aspects of Pathophysiology
Richard W. Martin, MD; Joseph Duffy, MD; Andrew G. Engel, MD; et al.
Ann Intern Med. 1990;113(2):124-134. doi:10.7326/0003-4819-113-2-124
Articles |  1 April 1987
Extracorporeal Enzyme Reactors for Depletion of Phenylalanine in Phenylketonuria
CLARA M. AMBRUS, M.D., Ph.D.; SIDNEY ANTHONE, M.D.; CSABA HORVATH, Ph.D.; et al.
Ann Intern Med. 1987;106(4):531-537. doi:10.7326/0003-4819-106-4-531
Brief Communications |  1 April 1987
Ornithine Transcarbamylase Deficiency: Adult Onset of Severe Symptoms
JAMES M. GILCHRIST, M.D.; ROSALIND A. COLEMAN, M.D.
Ann Intern Med. 1987;106(4):556-558. doi:10.7326/0003-4819-106-4-556
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)